Literature DB >> 29341277

Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply.

S Bonovas1,2, T Lytras3, G Nikolopoulos4, L Peyrin-Biroulet5, S Danese1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29341277     DOI： 10.1111/apt.14486

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  2 in total

1.  Interleukin-13 and interleukin-33 mRNA are underexpressed in the duodenal mucosa of German Shepherd dogs with chronic enteropathy.

Authors:  Aarti Kathrani; Victor Lezcano; Edward J Hall; Albert E Jergens; Yeon-Jung Seo; Jonathan P Mochel; Todd Atherly; Karin Allenspach
Journal:  J Vet Intern Med       Date:  2019-06-06       Impact factor: 3.333

Review 2.  Selective Tyrosine Kinase 2 Inhibition for Treatment of Inflammatory Bowel Disease: New Hope on the Rise.

Authors:  Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Inflamm Bowel Dis       Date:  2021-11-15       Impact factor: 5.325
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.